Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

LUN04-78

Pemetrexed (Alimta) in Patients with Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer

Abstracts/Posters/Presentations:

  • S. Jalal, D. Waterhouse, M. Edelman, S. Nattam, R. Ansari, K. Koneru, M. Yu, J. Shen, T. Breen, N. Hanna: Pemetrexed plus cetuximab in patients (pts) with recurrent non-small cell lung cancer (NSCLC): a phase I-IIa dose-ranging study from the Hoosier Oncology Group LUN04-78. Poster accepted to Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2007, Chicago, IL.
  • N. Hanna, R. Ansari, S. Bhatia, R. Govindan, D. Bruetman, M. Guarino, W. Fisher, A. White, T. Breen, B. Juliar. Pemetrexed in Patients (pts) with Relapsed Small Cell Lung Cancer (SCLC): A Phase II Study from the Hoosier Oncology Group LUN04-78. Presented as part of the Scientific Program in the Lung Cancer General Poster Session 2006 Annual Meeting of the American Society of Clinical Oncology. June 2-6, 2006, Atlanta, Georgia

Manuscripts/Articles:

  • Jalal, Shadia MD; Ansari, Rafat MD; Govindan, Ramaswamy MD; Bhatia, Sumeet MD; Bruetman, Daniel MD; Fisher, William MD; Masters, Gregory MD; White, Angela MBA; Stover, Daniel MT ; Yu, Menggang PhD; Hanna, Nasser MD. Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study LUN04-78. Journal of Thoracic Oncology. 4(1):93-96, January 2009.